Compositions for enhancing transport and antisense efficacy of nucleic acid analog into cells

Details for Australian Patent Application No. 2011200720 (hide)

Owner AVI BioPharma, Inc.

Inventors Iversen, Partrick L.; Moulton, Hong M.; Nelson, Michelle H.; Kroeker, Andrew D.; Stein, David A.

Agent Davies Collison Cave

Pub. Number AU-A-2011200720

Parent 2004235396

Filing date 18 February 2011

Wipo publication date 10 March 2011

International Classifications

C12N 15/113 (2010.01) Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 49/00 (2006.01) Preparations for testing

C12N 15/87 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

Event Publications

10 March 2011 Application Open to Public Inspection

  Published as AU-A-2011200720

10 March 2011 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011200721-Method and apparatus for advanced paging

2011200719-Method and apparatus for enhanced paging